Project: Develop an oral formulation for monoclonal antibodies

Acronym Bioralix (Reference Number: 11879)
Duration 30/04/2018
Project Topic In this project we want to develop an oral formulation for monoclonal antibodies (mAbs) that yields longer drug stability, easier administration, the opportunity of controlled release, has a high bioavailability and does not need a cold chain. We will make nanopartiles containing the mAbs by supercritical CO2 spray-drying and enclose them in microparticles. By encapsulating these particles the drugs can survive the stomach and the gut environment and will be released into the bloodstream.
Network Eurostars 2
Call Eurostars Cut-Off 8

Project partner

Number Name Role Country
1 InProPharma Laboratories B.V. Coordinator Netherlands
2 BiosanaPharma B.V. Partner Netherlands
3 LA-Bio Research Laboratory Partner South Africa